50 filings
8-K
TCRR
Tcr2 Therapeutics Inc
1 Jun 23
Completion of Acquisition or Disposition of Assets
4:10pm
8-K
TCRR
Tcr2 Therapeutics Inc
30 May 23
Submission of Matters to a Vote of Security Holders
4:17pm
8-K
TCRR
Tcr2 Therapeutics Inc
24 May 23
Entry into a Material Definitive Agreement
4:47pm
8-K
TCRR
Tcr2 Therapeutics Inc
22 May 23
Other Events
7:31am
8-K
TCRR
Tcr2 Therapeutics Inc
11 May 23
TCR2 Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:00am
8-K
90o0yp 52bg
23 Mar 23
TCR2 Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update
7:00am
8-K
j2tc8zvk1jwgu7ebitr
10 Mar 23
Regulation FD Disclosure
4:50pm
8-K
6g9taw4
6 Mar 23
Adaptimmune and TCR² Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors
6:37am
8-K
4iz69l8tzh9kb0tamf64
5 Jan 23
TCR2 Therapeutics Announces Pipeline Priorities for 2023
9:00am
8-K
on28d4kwefw1lxk4xbpq
3 Jan 23
Departure of Directors or Certain Officers
4:27pm
8-K
xddj xxfn10xg9cqc
8 Nov 22
TCR2 Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:00am
8-K
mwo1hzg8y7qdzmi
14 Oct 22
Submission of Matters to a Vote of Security Holders
4:17pm
8-K
ugx 23kj7ksrzep4
28 Sep 22
Regulation FD Disclosure
7:01am
8-K
g3yw04jqg1ebw
8 Aug 22
TCR2 Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:00am
8-K
602ophjl
27 Jun 22
TCR2 Therapeutics Appoints Industry and Finance Veteran Eric Sullivan as Chief Financial Officer
4:58pm
8-K
4p4 xwdtdx9oye5xzynv
12 May 22
TCR2 Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:02am
8-K
s259gi1k g1n2
22 Mar 22
TCR2 Therapeutics Reports Fourth Quarter 2021 Financial Results and Provides Corporate Update
7:29am
8-K
j7ll8j7e3uanv2 1pwxi
22 Nov 21
Departure of Directors or Certain Officers
7:00am
8-K
on4w2pndanc07n5eje
10 Nov 21
TCR2 Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
7:03am
8-K
73qioz iq0n
1 Nov 21
TCR2 Therapeutics Announces Expansion of U.S. Manufacturing Capacity
4:16pm